QQQ1.19%

Trending

META8.21%

Info

home Symbol SRRKnews

Exchange: NASDAQ·Updated 06:34 PM EDT

SRRKScholar Rock Holding Corp

$52.84

$2.16

(3.93%)

Today

Closed $52.84

$0.00

(0.00%)

After Hours

EarningsAug 6

Mkt Cap$6.59B

Vol1.3M

News

all

press releases

Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, announced...

Business Wire

More News

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the Company) today announced that the company granted inducement equity awards covering an aggregate of 134,345 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to purchase an aggregate of 50,936 shares of common stock...

Business Wire

Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance...

Business Wire

Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance...

Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the Company) today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 12,061 shares of common stock and...

Business Wire

Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and...

Business Wire

Jennison Associates LLC Acquires 1,188,676 Shares of Scholar Rock Holding Corporation $SRRK

Jennison Associates LLC grew its holdings in Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) by 74.0% during the 4th quarter, according to the company in its most recent filing with the...

MarketBeat

Scholar Rock (SRRK) Projected to Post Earnings on Thursday

Scholar Rock (NASDAQ:SRRK) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...

MarketBeat

Scholar Rock to Present at the BofA Securities 2026 Health Care Conference

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and...

Business Wire

Pictet Asset Management Holding SA Sells 126,964 Shares of Scholar Rock Holding Corporation $SRRK

Pictet Asset Management Holding SA trimmed its stake in Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) by 9.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,195,967 shares of the company's stock after sellin...

MarketBeat

...

Advertisement|Remove ads.